130 likes | 247 Views
Reasons for treatment discontinuation during 1 st year of ART: 2007-2008 data from 12 eastern European countries. XVIII International conference on AIDS, Vienna, 19 July 2010. Dr Irina Eramova, WHO Regional Office for Europe. Focus of the presentation.
E N D
Reasons for treatment discontinuation during 1st year of ART: 2007-2008 data from 12 eastern European countries XVIII International conference on AIDS, Vienna, 19 July 2010 Dr Irina Eramova, WHO Regional Office for Europe
Focus of the presentation • Coverage with HIV care by health systems in EE countries • ART interruptions and reasons • Conclusions
Methods (1) How many PLHIV were seen for care in 2008? • Cumulative number of HIV/AIDS cases as of end 2008 • ECDC/WHO surveillance report on HIV/AIDS • For RUS – presentation from FAC at CIS coordination body, 03.06.09 • Cumulative number of all deaths among PLHIV • Through WHO country staff and National AIDS Centers • Number of PLHIV seen for care in 2008 • WHO EURO questionnaire on health system response • National data from the countries • For RUS – presentation of Dr Onischenko at Suzdal conference 2009 • Some data from EST, LVA, TKM, and UZB were not available
Methods (2) How many PLHIV stopped ART within first year? • Health system survey through questionnaire • Global 13 and Regional 19 indicators, including • “Reasons for discontinuation of HAART within the first 12 months among all patients” • Analysis of an average data on HAART interruption for 2007 and 2008 • 12 EE countries (excluding RUS, EST, and TKM)
Percent of alive and known to health systems PLHIV seen for care in 2008
ART Discontinuation • How many PLHIV stop ART within 1st year? • 21%(671 of 3118 average) *Lack of data from RUS might affect the percentage of ART discontinuation
Reasons for ART discontinuation • 38% - Death • late presentation • 30% - Clinical decision, toxicity or unwillingness to continue ART • inadequate treatment preparedness • poor counselling on ARTand support of adherene • clinical decision to stop ART because of illicit drug use • Insufficient clinical management of treatment side effects • 21% - Unknown/other reasons • 11% - Lost to follow up
Conclusions • Health systems have to improve their performance in provision of treatment and care for PLHIV • There is a need to develop user-friendly services • There is an urgent need to increase the coverage with HIV care of those PLHIV already known to the health systems • There is a need for earlier HIV diagnosis and enrolment into care • There is a need to improve HIV case management ensuring continuum of careand adherence to ART • Electronic patient monitoring systemshould be introduced at clinical level
Acknowledgements • Anne-Marie RinderStengaard • Carlo Huber • WHO country staff • National counterparts from EE countries
Thank you! http://www.euro.who.int/en